… Kuriyama, Akira MD * ; Jackson, Jeffrey L. MD, MPH † ; Doi, Asako MD ‡ ; Kamiya, Toru
MD § … Drs Jackson and Kuriyama had full access to the data and take full responsibility …

Context Botulinum toxin A is US Food and Drug Administration approved for prophylactic
treatment for chronic migraines. Objective To assess botulinum toxin A for the prophylactic …

Background Postoperative pulmonary complications (PPCs) have an impact on the recovery
of adults after surgery. It is therefore important to establish whether preoperative respiratory …

Ramelteon is the first selective melatonin receptor agonist and currently is approved in the
United States and Japan for the treatment of insomnia. Our meta-analysis assessed the …

Objective: To evaluate the risks and benefits of using a circular stapler (CS) compared with
the hand-sewn (HS) method for the esophagogastric anastomosis after esophageal resection…

Importance Progression-free survival (PFS) has become a commonly used outcome to assess
the efficacy of new cancer drugs. However, it is not clear if delay in progression leads to …

Introduction Triage systems are scales developed to rate the degree of urgency among
patients who arrive at EDs. A number of different scales are in use; however, the way in which …

Background Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has been treated
with several different interventions with limited success. This meta-analysis aims to review all …

Background: A critical marker of high-quality systematic reviews is the identification and
inclusion of all relevant, important studies. Up to 78% of systematic reviews have language …

Suvorexant is a dual orexin receptor agonist and is currently approved for the treatment of
insomnia in the United States and Japan. We conducted a systematic review and meta-…